Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,976
Total Claims
$2.2M
Drug Cost
6,890
Beneficiaries
$315
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-73%
Cost per patient vs peers
$315 vs $1,174 avg
+30%
Brand preference vs peers
11.5% vs 8.9% avg
Brand vs Generic
Brand: 2,386 claims · $1.7M
Generic: 18,381 claims · $495K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 196 | $249K |
| Empagliflozin | 107 | $151K |
| Dulaglutide | 76 | $129K |
| Sitagliptin Phosphate | 80 | $110K |
| Insulin Glargine,hum.Rec.Anlog | 128 | $89K |
| Linagliptin | 56 | $81K |
| Rivaroxaban | 60 | $76K |
| Semaglutide | 52 | $71K |
| Dapagliflozin Propanediol | 35 | $41K |
| Insulin Aspart | 45 | $41K |
| Sacubitril/Valsartan | 16 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $34K |
| Sitagliptin Phos/Metformin Hcl | 27 | $33K |
| Insulin Glargine,hum.Rec.Anlog | 45 | $32K |
| Mirabegron | 28 | $27K |
Prescribing Profile
Patient Profile
71
Avg Age
58%
Female
1.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data